Languages

Bruker Launches the VERTEX NEO Platform

The Next-Generation high-end vacuum FTIR systems

BILLERICA, Massachusetts – February 6th, 2025 – Bruker Corporation (Nasdaq: BRKR) today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This release marks a continuation of providing high-end Fourier-Transform Infrared (FTIR) instrumentation for unparalleled and disturbance-free academic and industrial research and development. The VERTEX NEO R, the successor of the VERTEX 70v, combines significant advancement in high-end FTIR research instrumentation with Bruker’s proven MultiTect detector technology. It also features Bruker’s first unique Vacuum ATR accessory.

MultiTect provides unprecedented advantages for advanced FTIR research by offering broad spectral range detection in one go. Always having the optimal detector ready to operate makes measurements convenient for the user and even makes plug & play obsolete for the new platform.

The Vacuum ATR accessory enables ATR measurements with the complete optical path under vacuum, as well as  full access to the ATR crystal and the sample at the top of the instrument.  This makes venting between measurements a thing of the past and complex scientifc setups around the samples are also possible for the future user community. The Vacuum ATR builds on the Bruker Platinum ATR accessory with a diamond crystal. This ATR acessory enables  measurements from MIR to FIR, or even the THz spectral region, and is suitable for a wide range of samples from solids to (volatile) liquids.

Apart from the Vacuum ATR and the MultiTect technology, the VERTEX NEO R offers further innovations such as interleaved time-resolved FTIR spectroscopy. Altogether, this makes the VERTEX NEO R a perfect tool for high-end FTIR research e.g., in the field of catalytic investigations, battery material development or semiconductor research.

Prof. Dr. Holger Schönherr, Physical Chemistry I and Research Center of Micro and Nanochemistry and (Bio)Technology (Cμ), University of Siegen commented: “Trusting in Bruker’s technological leadership in FT-IR research instrumentation, we were considering buying a Bruker vacuum FT-IR spectrometer for our new INCYTE research center (Interdisciplinary Research Center for Nanoanalytics, Nanochemistry and Cyber-Physical Sensor Technologies). We wanted to get a modern vacuum system for high-end FTIR research with the best future support perspective. Our long experience with Bruker’s vacuum FT-IR spectrometers together with the new Vacuum-ATR option, which gives best spectral quality combined with ease of handling, convinced us to decide for VERTEX NEO R.”

“The VERTEX NEO R represents a significant development for both Bruker and our customers. By combining state-of-the-art technology with user-friendly features, we are enabling researchers to explore new frontiers in fields such as catalytic investigations, battery material development, and semiconductor research. This launch underscores our mission to support the scientific community with the best tools available” summarizes Dr. Andreas Kamlowski, President of the Bruker Optics Division.

VERTEX NEO R with Vacuum ATR unit

About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new
applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

Media Contact
Natalie Spahl
Head of Global Marketing
Bruker Optics Division
T: +49 173 9662425
E: Natalie.spahl@bruker.com